drugset / Trial / NCT01601158

Umbilical Cord Blood Therapy for Children With Global Developmental Delay

NCT01601158

Completed 10 enrolled MinYoung Kim, M.D.
NaSingle-groupOpen-labelTreatment

Summary

This open-label study aims to evaluate the safety and efficacy of umbilical cord blood therapy for children with global developmental delay.

Timeline

Start
2012-05
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Intravenous